AONC OTC
American Oncology Network, Inc.
1W: +0.0%
1M: +10.0%
3M: +10.0%
YTD: -8.3%
1Y: +29.4%
3Y: -16.0%
5Y: +12.7%
$11.00
+1.00 (+10.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$470M
+25.6% ▲
4Y CAGR: +889.6%
Total Liabilities
$362M
+19.3% ▲
4Y CAGR: +998.6%
Shareholders Equity
$19M
+111.6% ▲
4Y CAGR: +427.9%
Cash & Investments
$73M
+13.6% ▲
4Y CAGR: +634.2%
Total Debt
$147M
+14.8% ▲
Net Debt
$85M
-15.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $25K | $27M | $27M | $29M | $63M |
| Short-Term Investments | $0 | $0 | $10M | $35M | $10M |
| Cash & ST Investments | $25K | $27M | $37M | $64M | $73M |
| Net Receivables | $0 | $138M | $166M | $165M | $190M |
| Inventory | $0 | $35M | $36M | $45M | $61M |
| Other Current Assets | $0 | $8M | $3M | $4M | $8M |
| Total Current Assets | $25K | $208M | $242M | $278M | $331M |
| Property, Plant & Equip. | $0 | $33M | $76M | $84M | $99M |
| Goodwill & Intangibles | $0 | $1M | $1M | $1M | $13M |
| Long-Term Investments | $0 | $334M | $0 | $1M | $0 |
| Other Non-Current Assets | $24K | $6M | $9M | $8M | $27M |
| Total Non-Current Assets | $24K | $40M | $84M | $97M | $139M |
| Total Assets | $49K | $248M | $326M | $374M | $470M |
| — Liabilities — | |||||
| Accounts Payable | $0 | $93M | $106M | $128M | $171M |
| Short-Term Debt | $0 | $0 | $10M | $8M | $4M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $25K | $21M | $13M | $22M | $29M |
| Total Current Liabilities | $25K | $119M | $141M | $169M | $217M |
| Long-Term Debt | $0 | $64M | $80M | $81M | $87M |
| Other Non-Current Liab. | $0 | $6M | $6M | $14M | $10M |
| Total Non-Current Liabilities | $0 | $69M | $123M | $135M | $145M |
| Total Liabilities | $25K | $22M | $264M | $304M | $362M |
| — Equity — | |||||
| Common Stock | $719 | $334M | $36M | $4K | $4K |
| Retained Earnings | -$834 | -$21M | $26M | -$162M | -$102M |
| Accumulated OCI | $0 | $0 | -$117K | $81K | $28K |
| Total Stockholders Equity | $24K | $313M | $62M | -$162M | $19M |
| Total Liabilities & Equity | $49K | $335M | $326M | $374M | $470M |
| — Key Metrics — | |||||
| Total Debt | $0 | $64M | $127M | $128M | $147M |
| Net Debt | -$25K | $36M | $100M | $100M | $85M |
| Total Investments | $0 | $334M | $10M | $37M | $10M |